The purpose of this systematic review was to summarize and critically appraise research developing or validating instruments to assess patient-reported safety, efficacy, and/or misuse in ongoing opioid therapy for chronic pain. Our search included the following datasets: OvidSP MEDLINE (1946-August 2012), OvidSP PsycINFO (1967-August 2012), Elsevier Scopus (1947-August 2012), OvidSP HaPI (1985-August 2012, and EBSCO CINAHL (1981( -August 2012. Eligible studies were published in English and pertained to adult, nonsurgical/interventional populations. Two authors independently assessed inclusion criteria. Each study was evaluated by 2 authors to assess the sources and content of items, types of psychometric tests, their results, and quality of diagnostic accuracy testing, when applicable. Of 1874 citations found in the initial search, we identified 14 studies meeting our inclusion criteria, describing 9 different instruments. Individual items were derived from surveys of content experts, literature reviews, and adapted non-patient-reported items. Misuse-related items were most prevalent (60/144; 42%), followed by safety (47/144; 33%), with efficacy having the fewest items (17/144; 12%). The studies employed a wide variety of psychometric tests, with most demonstrating statistical significance, but several potential sources of bias and generalizability limitations were identified. Lack of testing in clinical practice limited assessment of feasibility. The dearth of safety and efficacy items and lack of testing in clinical practice demonstrates areas for further research.
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Introduction
The challenges facing patients and providers in managing ongoing opioid analgesic therapy for chronic pain are complex. Benefit of long-term opioid therapy, for which there are scant data to guide providers [22] , must be balanced against myriad potential undesired outcomes including safety concerns, ranging from mild toxicities to overdose and death [41] ; inadequate efficacy, which may mean continued patient suffering and unwarranted exposure to toxicities; and misuse of these potent medications. To help patients and providers navigate these challenges and optimize therapy, experts advise a strategy of frequent re-assessment of safety, efficacy, and misuse in patients on opioids to inform treatment decisions [7, 38] . To date, however, there is no widely accepted instrument or protocol to facilitate this monitoring strategy.
The strategies for monitoring various aspects of opioid therapy can be divided into those that rely on patient report, for example, asking patients about side effects and therapeutic effects; and those that do not, for example, observing a patient for somnolence, performing urine drug testing, or querying a prescription monitoring database for evidence of multiple prescribers. While the latter strategies are important for high-quality clinical care, in this review we focus solely on instruments that collect patient-reported data because non-patient-reported measures have been recently reviewed elsewhere [30, 36] . Additionally, we recognize that patient report is the foundation of monitoring the impact of pain treatment [15] and acknowledge the increasing emphasis on patient-reported outcomes in assessing quality of care [6, 12] . As such, the current study was designed to systematically review the psychometric development and testing of patient-reported instruments assessing safety, efficacy, and misuse of opioids and, when possible, to assess the operating characteristics of these instruments compared to a reference standard assessment. This review addresses a void in the literature, as previous reviews have
